FDA Orders Recall and Issues Warning Over Eyedrops From CVS, Rite Aid and Others

FDA Orders Recall and Issues , Warning Over Eyedrops, From CVS, Rite Aid and Others.

'The Independent' reports that health regulators in the United States have warned consumers not to use a number of over-the-counter eyedrops.

The Food and Drug Administration issued an advisory on over two dozen lubricating eyedrops due to a risk of infections that could result in blindness.

Six companies, including CVS Health and Target, were ordered to recall the products after FDA inspectors reported unsanitary conditions and bacteria at production facilities.

Six companies, including CVS Health and Target, were ordered to recall the products after FDA inspectors reported unsanitary conditions and bacteria at production facilities.

In an October 27 statement, the FDA warned consumers to stop using the products and avoid purchasing any that can still be found in stores.

.

'The Independent' reports that the FDA did not disclose which factory was involved or when the agency conducted its inspection.

While no infections had been reported at the time of the FDA's announcement, the agency directed consumers and doctors to submit cases on its online reporting system.

.

While no infections had been reported at the time of the FDA's announcement, the agency directed consumers and doctors to submit cases on its online reporting system.

.

Earlier in 2023, federal officials connected an outbreak of a drug-resistant bacteria to eyedrop products produced by two companies, EzriCare and Delsam Pharma.

According to the Centers for Disease Control and Prevention, over 80 people have tested positive for eye-infections caused by this rare strain of bacteria.

.

At the time, the companies' products were recalled after inspectors visited the factory in India that produced the eyedrops.

Inspectors discovered problems, including inadequate sterility measures with how the eyedrops were both produced and tested.